Pinnacle Associates LTD Coll Plant Biotechnologies LTD Transaction History
Pinnacle Associates LTD
- $6.59 Billion
- Q2 2025
A detailed history of Pinnacle Associates LTD transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Pinnacle Associates LTD holds 507,193 shares of CLGN stock, worth $1.31 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
507,193
Previous 489,193
3.68%
Holding current value
$1.31 Million
Previous $1.26 Million
45.4%
% of portfolio
0.01%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding CLGN
# of Institutions
21Shares Held
2.66MCall Options Held
0Put Options Held
0-
Villere St Denis J & CO LLC547KShares$1.41 Million0.08% of portfolio
-
Investment Management Of Virginia LLC464KShares$1.2 Million0.63% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$713,1892.69% of portfolio
-
Heights Capital Management, Inc San Francisco, CA275KShares$709,7110.1% of portfolio
-
Amh Equity LTD161KShares$414,9900.3% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $28.6M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...